Moody Aldrich Partners LLC Ligand Pharmaceuticals Inc Transaction History

Moody Aldrich Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$86.25 - $120.16 $1.44 Million - $2 Million	-16,651 Closed	0 $0
Q2 2019 Jul 26, 2019	BUY	$107.38 - $129.34 $70,548 - $84,976	657 Added 4.11%	16,651 $1.9 Million
Q1 2019 May 03, 2019	SELL	$105.93 - $142.47 $789,390 - $1.06 Million	-7,452 Reduced 31.78%	15,994 $2.01 Million
Q4 2018 Feb 12, 2019	BUY	$128.36 - $272.13 $330,527 - $700,734	2,575 Added 12.34%	23,446 $3.18 Million
Q3 2018 Oct 31, 2018	SELL	$211.18 - $274.49 $1.17 Million - $1.53 Million	-5,561 Reduced 21.04%	20,871 $5.73 Million
Q2 2018 Aug 13, 2018	BUY	$150.77 - $207.98 $3.99 Million - $5.5 Million	26,432 New	26,432 $5.48 Million

247

17.5M

61K

7.8K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.64B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Moody Aldrich Partners LLC with notifications on news.